Virus therapy takes on deadly brain cancer in early trial
Disease control
ENROLLING_BY_INVITATION
This study tests a new oncolytic virus (Ad-TD-nsIL12) in 40 adults with high-grade glioma, a fast-growing brain tumor. The virus is designed to infect and kill cancer cells while boosting the immune system. The main goal is to see how many patients survive at least 12 months afte…
Phase: PHASE1, PHASE2 • Sponsor: Xiaorong Wu • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC